HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Carrieri Selected Research

Tocainide (Tonocard)

12/2021Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels.
3/2014N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Carrieri Research Topics

Disease

7Alzheimer Disease (Alzheimer's Disease)
07/2022 - 11/2014
5Infections
06/2022 - 07/2009
5Neoplasms (Cancer)
01/2021 - 04/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2002
2Myotonia
12/2021 - 03/2014
2Neuroblastoma
10/2020 - 09/2019
2Carcinoma (Carcinomatosis)
06/2016 - 09/2013
2Adenocarcinoma
06/2016 - 09/2013
1Communicable Diseases (Infectious Diseases)
06/2022
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Neuroinflammatory Diseases
01/2022
1Inflammation (Inflammations)
01/2022
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2021
1Prostatic Neoplasms (Prostate Cancer)
09/2021
1Diffuse Intrinsic Pontine Glioma
01/2021
1Metabolic Diseases (Metabolic Disease)
05/2016
1Seizures (Absence Seizure)
03/2003

Drug/Important Bio-Agent (IBA)

3Neuroprotective AgentsIBA
10/2020 - 06/2016
2Tocainide (Tonocard)FDA Link
12/2021 - 03/2014
2Amyloid (Amyloid Fibrils)IBA
10/2020 - 09/2019
2ButyrylcholinesteraseIBA
10/2020 - 09/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2018 - 09/2013
2lubeluzoleIBA
06/2016 - 09/2013
2Biocompatible Materials (Biomaterials)IBA
03/2016 - 12/2013
1Cholinergic Agents (Cholinergics)IBA
07/2022
1Donepezil (Aricept)FDA LinkGeneric
07/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2022
1Antipsychotic Agents (Antipsychotics)IBA
06/2022
1Antidepressive Agents (Antidepressants)IBA
06/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2022
1Anti-Bacterial Agents (Antibiotics)IBA
06/2022
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2022
1Biological ProductsIBA
01/2022
1Sodium Channel BlockersIBA
12/2021
1AndrogensIBA
09/2021
1Tenuazonic AcidIBA
01/2021
1Mannich BasesIBA
01/2021
1TIC10 compoundIBA
01/2021
1ProdrugsIBA
01/2021
1dipinacoline glutamateIBA
01/2021
1Dopamine AntagonistsIBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
10/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020
1EndocannabinoidsIBA
09/2020
1EnzymesIBA
09/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
09/2019
1Peptides (Polypeptides)IBA
09/2019
1indoleIBA
09/2019
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2019
1AcetylcholinesteraseIBA
09/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2016
1Methanol (Carbinol)IBA
11/2014
1MicroRNAs (MicroRNA)IBA
04/2014
1Paclitaxel (Taxol)FDA LinkGeneric
09/2013
1LigandsIBA
07/2009
1StrychnineIBA
03/2003
1Pentylenetetrazole (Metrazol)IBA
03/2003
1Monoamine Oxidase (MAO)IBA
11/2002
1Selegiline (E250)FDA LinkGeneric
11/2002

Therapy/Procedure

3Therapeutics
07/2022 - 04/2014
2Drug Therapy (Chemotherapy)
09/2021 - 05/2018
1Radiotherapy
09/2021
1Investigational Therapies (Experimental Therapy)
09/2021
1Highly Active Antiretroviral Therapy (HAART)
07/2009